Magnetic resonance spectroscopy detects altered metabolism in the brainstem of female mice, suggesting sex-specific changes in Alzheimer’s disease.
Motivation: Identifying pre-diagnostic biomarkers is crucial in the context of Alzheimer's disease (AD). Goal(s): We aimed to assess the predictive capability of magnetic resonance spectroscopy (MRS) in identifying early stages of AD. Approach: MRS was conducted on the brainstem of both male and female APP/PS1 mice, with the results validated histopathologically and further corroborated through behavioral experiments. Results: MRS revealed altered astrocyte metabolism in the brainstem of female APP/PS1 mice, but not in males. Our findings highlight the predictive potential of brainstem MRS as an early biomarker for detecting sex-specific onset of pathological changes in AD. Impact: Including brainstem MRS results in routine clinical evaluations could allow clinicians to offer tailored lifestyle advice or enroll individuals in prevention trials focused on maintaining brain health.
No takes yet. Share an insight, caveat, or question.
Kushwaha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: